8-K: Cyabra, Inc. Restructures Convertible Preferred Stock

Cyabra, Inc. announces the completion of agreements to exchange Series C Preferred Stock and convert Series A and B Preferred Shares, amending conversion prices and removing anti-dilution protections.

Summary

• Cyabra, Inc. has completed transactions involving its Series C, Series A, and Series B Convertible Preferred Stock.
• An exchange agreement with Alpha Capital Anstalt for Series C Preferred Stock was finalized on September 9, 2026.
• This exchange involved $10,660,000 worth of Series C Preferred Shares, resulting in the issuance of pre-funded warrants, Series A common warrants, and Series B common warrants.
• A conversion agreement with holders of Series A and Series B Convertible Preferred Stock was also closed on September 9, 2026.
• The conversion agreements amended the terms to reduce the conversion price for Series A and Series B Preferred Shares to $0.435 per share and removed certain anti-dilution protections.
• Stockholder approval for these agreements was received on September 2, 2026.
• The Series C Preferred Shares were cancelled and restored to authorized but unissued status.
• Similarly, the Series A and Series B Preferred Shares were cancelled and restored to authorized but unissued status upon conversion.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, primarily focused on restructuring existing convertible securities rather than introducing new capital or significant operational changes.

Positives

• Reduced conversion price for Series A and Series B Preferred Shares to $0.435, potentially making conversion more attractive.
• Removal of certain anti-dilution protections, which can benefit existing common stockholders by limiting future dilution.
• Successful completion of exchange and conversion agreements, resolving outstanding preferred stock obligations.
• Cancellation of Series C Preferred Shares, reducing the outstanding preferred stock count.

Negatives

• Issuance of a significant number of pre-funded warrants and common warrants, which could lead to future dilution.
• The exchange of Series C Preferred Stock for warrants and common stock represents a conversion of debt-like instruments into equity-like instruments.

Risks

• Potential for future dilution from the exercise of pre-funded warrants and common warrants issued in the exchange and conversion.
• The amended conversion price of $0.435 per share could still be a point of focus for future equity issuances.
• The removal of anti-dilution protections could leave preferred stockholders less protected against future stock price declines.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The primary focus is on the completion of equity restructuring transactions.

Management Comments

• The filing is signed by Dan Brahmy, Chief Executive Officer, and Yael Sandler, Chief Financial Officer, indicating their authorization and oversight of these transactions.

Industry Context

StockSavvy.ai notes that the restructuring of convertible securities and the adjustment of conversion prices are common strategies for companies seeking to simplify their capital structure or improve the terms for future equity raises. The removal of anti-dilution provisions is often a point of negotiation to align incentives between existing shareholders and new investors or converting security holders.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for future dilution from warrant exercises, but also potential benefit from removal of certain anti-dilution protections. The reduced conversion price may make conversion more likely.
• Preferred Stockholders (Series A & B): Benefit from a lower conversion price, making conversion to common stock more accessible.
• Preferred Stockholders (Series C): Have exchanged their preferred stock for warrants and common stock, effectively converting their holdings.
• Warrant Holders: Will have the right to purchase common stock at specified exercise prices, subject to warrant terms.

Next Steps

• The company has completed the exchange of Series C Preferred Stock and the conversion of Series A and B Preferred Shares.
• The amended Certificates of Designation for Series A and Series B Convertible Preferred Stock have been filed.
• The issued warrants (Pre-Funded, Series A Common, Series B Common) are now exercisable under their respective terms.

Key Dates

Recommendation

The filing details the completion of previously announced equity restructuring transactions, including the exchange of preferred stock for warrants and the amendment of conversion terms. While these actions resolve prior agreements and simplify the capital structure by removing certain preferred stock classes, they also introduce potential future dilution through the issuance of warrants. The lack of new operational or financial performance data makes it difficult to assess the company's intrinsic value beyond the capital structure adjustments. Therefore, a 'hold' recommendation is appropriate pending further operational updates or financial results.

Keywords

Convertible Preferred Stock, Equity Exchange, Warrants, Conversion Price, Anti-dilution, Stockholder Approval, Capital Restructuring